457 related articles for article (PubMed ID: 33678748)
1. Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody.
Kishida D; Ushiyama S; Shimojima Y; Ueno KI; Kurashina JI; Shirai T; Sekijima Y
Intern Med; 2021 Aug; 60(16):2697-2700. PubMed ID: 33678748
[TBL] [Abstract][Full Text] [Related]
2. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
Yashiro M; Asano T; Sato S; Kobayashi H; Watanabe H; Miyata M; Migita K
Fukushima J Med Sci; 2018; 64(2):89-94. PubMed ID: 30158335
[TBL] [Abstract][Full Text] [Related]
3. Serum KL-6 level is a prognostic marker in patients with anti-MDA5 antibody-positive dermatomyositis associated with interstitial lung disease.
Ye Y; Fu Q; Wang R; Guo Q; Bao C
J Clin Lab Anal; 2019 Oct; 33(8):e22978. PubMed ID: 31301087
[TBL] [Abstract][Full Text] [Related]
4. Anti-MDA5 Antibody-Positive Dermatomyositis Presenting with Cellulitis-Like Erythema on the Mandible as an Initial Symptom.
Hattori Y; Matsuyama K; Takahashi T; Shu E; Kanoh H; Seishima M
Case Rep Dermatol; 2018; 10(2):110-114. PubMed ID: 29867431
[TBL] [Abstract][Full Text] [Related]
5. A case of anti-SAE1/2 antibody-positive dermatomyositis with extensive panniculitis: A possible cutaneous manifestation of treatment resistance.
Fujisaki M; Kasamatsu H; Nishimura K; Yoshida Y; Muneishi Y; Yamaguchi T; Nishino I; Konishi R; Ichimura Y; Okiyama N; Oyama N; Hasegawa M
J Dermatol; 2024 Feb; 51(2):301-306. PubMed ID: 37830399
[TBL] [Abstract][Full Text] [Related]
6. An autopsy case of anti-MDA5 antibody-positive amyopathic dermatomyositis with an initial manifestation of panniculitis on the left upper arm.
Onose T; Kido T; Okada I; Yamazaki M; Hounoki H; Makino T; Yamauchi N; Matsushita T; Tobe K; Shinoda K
Mod Rheumatol Case Rep; 2023 Dec; 8(1):86-90. PubMed ID: 37340862
[TBL] [Abstract][Full Text] [Related]
7. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Yamaguchi K; Yamaguchi A; Kashiwagi C; Sawada Y; Taguchi K; Umetsu K; Oshima K; Uchida M; Suzuki M; Kono S; Takemura M; Masubuchi H; Kitahara S; Hara K; Maeno T; Motegi SI; Muro Y; Sakairi T; Hisada T; Kurabayashi M
Respir Med; 2018 Jul; 140():1-5. PubMed ID: 29957268
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis.
Sakamoto N; Ishimoto H; Nakashima S; Yura H; Miyamura T; Okuno D; Hara A; Kitazaki T; Kakugawa T; Ishimatsu Y; Satoh M; Mukae H
Intern Med; 2019 Mar; 58(6):837-841. PubMed ID: 30449789
[TBL] [Abstract][Full Text] [Related]
9. Panniculitis associated with amyopathic dermatomyositis.
Azevedo PO; Castellen NR; Salai AF; Barbosa FS; Alves CAXM; Pinto CAL
An Bras Dermatol; 2018; 93(1):119-121. PubMed ID: 29641712
[TBL] [Abstract][Full Text] [Related]
10. Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody.
Hasegawa A; Shimomura Y; Kibune N; Koshio J; Umemori Y; Abe R
Clin Exp Dermatol; 2017 Jul; 42(5):551-553. PubMed ID: 28543278
[No Abstract] [Full Text] [Related]
11. Anti-MDA5 antibody-positive dermatomyositis with rapidly progressive interstitial lung disease: report of two cases.
Mehta AA; Paul T; Cb M; Haridas N
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33910791
[TBL] [Abstract][Full Text] [Related]
12. [Amyopathic dermatomyositis (DM) with anti-MDA5 antibodies, associated with bullous pemphigoid, Sjögren syndrome and gastric MALT lymphoma].
Garcia B; Dabouz F; Pascal L; Gillard M; Modiano P
Ann Dermatol Venereol; 2017 Oct; 144(10):629-633. PubMed ID: 28668260
[TBL] [Abstract][Full Text] [Related]
13. Treatment strategies in MDA5-positive clinically amyopathic dermatomyositis: a single-center retrospective analysis.
Hirsch S; Pöhler GH; Seeliger B; Prasse A; Witte T; Thiele T
Clin Exp Med; 2024 Feb; 24(1):37. PubMed ID: 38367089
[TBL] [Abstract][Full Text] [Related]
14. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
Koichi Y; Aya Y; Megumi U; Shunichi K; Masafumi S; Hiroaki M; Masahiko K; Shinsuke K; Manabu U; Kenichiro H; Fumiaki A; Nozomi A; Toshitaka M; Masayoshi Y; Chikako K; Yoshinao M; Tatsuo S; Masahiko K
Mod Rheumatol; 2017 May; 27(3):536-540. PubMed ID: 25698373
[TBL] [Abstract][Full Text] [Related]
15. Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.
Nishioka A; Tsunoda S; Abe T; Yoshikawa T; Takata M; Kitano M; Matsui K; Nakashima R; Hosono Y; Ohmura K; Mimori T; Sano H
Mod Rheumatol; 2019 Sep; 29(5):814-820. PubMed ID: 30449228
[No Abstract] [Full Text] [Related]
16. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
Moghadam-Kia S; Oddis CV; Sato S; Kuwana M; Aggarwal R
J Rheumatol; 2017 Mar; 44(3):319-325. PubMed ID: 28089977
[TBL] [Abstract][Full Text] [Related]
17. Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy.
Pau-Charles I; Moreno PJ; Ortiz-Ibáñez K; Lucero MC; Garcia-Herrera A; Espinosa G; Nicolás JM; Castro P; Grau JM; Casciola-Rosen L; Mascaró JM
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1097-1102. PubMed ID: 25243267
[TBL] [Abstract][Full Text] [Related]
18. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis.
Matsushita T; Mizumaki K; Kano M; Yagi N; Tennichi M; Takeuchi A; Okamoto Y; Hamaguchi Y; Murakami A; Hasegawa M; Kuwana M; Fujimoto M; Takehara K
Br J Dermatol; 2017 Feb; 176(2):395-402. PubMed ID: 27452897
[TBL] [Abstract][Full Text] [Related]
19. Ulcerative rash in a patient with anti-MDA5 antibody-associated clinically amyopathic dermatomyositis.
Shao Q
Clin Rheumatol; 2023 Sep; 42(9):2515-2516. PubMed ID: 37256386
[No Abstract] [Full Text] [Related]
20. Early initiation of plasma exchange therapy for a patient with anti-MDA5 autoantibody-positive dermatomyositis developing rapidly progressive interstitial lung disease.
Sasaki N; Ishii A; Kurabayashi T; Sugiyama M; Izumi Y; Nakagome Y; Hirano K; Sasaki S; Kondo Y; Nogi S; Nishikawa A; Hosono Y; Yamada C; Sato S
Mod Rheumatol Case Rep; 2021 Jan; 5(1):87-94. PubMed ID: 33048020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
